Do you preferentially use 10MV over 6MV in CNS IMRT treatments to prevent alopecia?  

Several radiation oncologists have switched from 6MV to 10MV for cranial IMRT plans to prevent alopecia. Is this theoretical or do we have data? And are there any notable drawbacks to the switch (assuming target coverage and OAR constraints are still met)? 



Answer from: Radiation Oncologist at Community Practice